| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 85.20 mm | 85.20 mm | 85.20 mm | 85.20 mm | 85.20 mm | |
| Cash burn (monthly) | 2.77 mm | 908.33 k | 20.10 mm | 31.90 mm | 22.12 mm | |
| Cash used (since last report) | 7.75 mm | 2.54 mm | 56.27 mm | 89.30 mm | 61.91 mm | |
| Cash remaining | 77.45 mm | 82.66 mm | 28.93 mm | -4.10 mm | 23.29 mm | |
| Runway (months of cash) | 28.0 | 91.0 | 1.4 | -0.1 | 1.1 | |
| 13F holders | Current |
|---|---|
| Total holders | 209 |
| Opened positions | 52 |
| Closed positions | 26 |
| Increased positions | 81 |
| Reduced positions | 44 |
| 13F shares | Current |
|---|---|
| Total value | 1.77 tn |
| Total shares | 75.45 mm |
| Total puts | 30.10 k |
| Total calls | 159.40 k |
| Total put/call ratio | 0.2 |
| Largest owners | Shares | Value |
|---|---|---|
| EcoR1 Capital | 6.73 mm | $179.06 bn |
| Vanguard | 6.67 mm | $177.60 bn |
| BLK BlackRock | 6.26 mm | $166.61 bn |
| T. Rowe Price | 3.99 mm | $106.19 mm |
| PFE Pfizer | 3.46 mm | $326.63 mm |
| Avidity Partners Management | 2.99 mm | $79.54 bn |
| RTW Investments | 2.97 mm | $79.01 bn |
| FMR | 2.68 mm | $71.32 bn |
| Citadel Advisors | 2.64 mm | $70.26 bn |
| Paradigm Biocapital Advisors | 2.44 mm | $64.90 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Jun 24 | Saik Andrew | Common Stock | Grant | Acquire A | No | No | 0 | 61,409 | 0.00 | 61,409 |
| 24 Jun 24 | Saik Andrew | Stock Option Common Stock | Grant | Acquire A | No | No | 24.97 | 94,418 | 2.36 mm | 94,418 |
| 17 Jun 24 | Angela M Cacace | Common Stock | Grant | Acquire A | No | No | 0 | 15,995 | 0.00 | 51,852 |
| 17 Jun 24 | Angela M Cacace | Stock Option Common Stock | Grant | Acquire A | No | No | 24.94 | 24,632 | 614.32 k | 24,632 |
| 29 May 24 | Norwalk Leslie V | Common Stock | Grant | Acquire A | No | No | 0 | 5,899 | 0.00 | 10,020 |
| 29 May 24 | Norwalk Leslie V | Stock Option Common Stock | Grant | Acquire A | No | No | 33.9 | 9,070 | 307.47 k | 9,070 |
